HOPKINSON CRAIG C. (EVP R&D, Chief Medical Officer) sold 10.4% of their position (9K shares) of ALKERMES PLC. on the open market
Open‑market sale worth $375.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/1/2026ACC: 0001520262-26-000097
Officer· EVP R&D, Chief Medical Officer
Since Mar 2026
-9K
Net shares
Net seller
$375.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 14K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+5K
Price / share
$19.34
Trade value
$96.70K
% of position
6.1%
6/1/2026
81.39K→86.39K
Ordinary Shares
Direct
Shares
−9K
Price / share
$41.67
Trade value
$375.04K
% of position
10.4%
6/1/2026
86.39K→77.39K
Total
Net shares
−4K
Net value
-$278.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/1/2026 | M · Option Exercise | +5K | $19.34 | $96.70K | 6.1% | 81.39K | 86.39K |
| Ordinary Shares Direct | 6/1/2026 | S · Sale | −9K | $41.67 | $375.04K | 10.4% | 86.39K | 77.39K |
| Total | −4K | -$278.34K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Ordinary Shares
5K shares
Shares
−5K
Strike price
19.34
Held after
6.36K
Exercisable
—
6/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Ordinary Shares5K shares | 6/1/2026 | M · Option Exercise | −5K | 19.34 | — | 6.36K |